Sarcomatoid, Trp53;Nf2 codeleted tumors are transcriptionally distinct from cancers containing either Trp53 or Nf2 deletions alone based on PCA (Supplementary Fig. S8A; Supplementary Table S7). The gene discussed is NF2; the disease is cancer.